Back to Search Start Over

Resveratrol Protects Purkinje Neurons and Restores Muscle Activity in Rat Model of Cerebellar Ataxia.

Authors :
Ghorbani, Zeynab
Farahani, Reza Mastery
Aliaghaei, Abbas
Khodagholi, Fariba
Meftahi, Gholam houssein
Danyali, Samira
Abdollahifar, Mohammad Amin
Daftari, Mahtab
Boroujeni, Mahdi Eskandarian
Sadeghi, Yousef
Source :
Journal of Molecular Neuroscience; May2018, Vol. 65 Issue 1, p35-42, 8p
Publication Year :
2018

Abstract

Cerebellar ataxia (CA) is regarded as a miscellaneous cluster of brain disorders related to the cerebellum. Resveratrol is a naturally occurring polyphenolic compound. Previous reports suggest that resveratrol confers neuroprotection in various animal models of brain damage. Indeed, we considered it invaluable to investigate whether a treatment with resveratrol has a therapeutic role against CA induced by 3-acetylpyridine (3-AP) in rats. In addition, no investigation has examined neuroprotective effect of resveratrol in rat model of CA. Initially, 3-AP administration generated CA rat models followed by intraperitoneal injection with resveratrol. Then, motor performance and muscle electromyography (EMG) activity were assessed. Moreover, the anti-apoptotic role of resveratrol in CA and its relationship to protection of Purkinje cells were explored. According to what we have found, resveratrol administration improved the muscle activity and movement coordination in 3-AP-lesioned rats. Also under resveratrol treatment, the total number of the Purkinje neurons increased whereas a reduction in apoptotic bodies was observed. In conclusion, post-treatment with resveratrol evidently ameliorated motor performance as well as muscle activity accompanied by a protection of Purkinje cells in ataxic rats. [ABSTRACT FROM AUTHOR]

Details

Language :
English
ISSN :
08958696
Volume :
65
Issue :
1
Database :
Complementary Index
Journal :
Journal of Molecular Neuroscience
Publication Type :
Academic Journal
Accession number :
129739032
Full Text :
https://doi.org/10.1007/s12031-018-1065-7